A Phase II Study of Bevacizumab and Everolimus as Treatment for Refractory Metastatic Renal Cell Carcinoma
2013 ◽
Vol 11
(2)
◽
pp. 100-106
◽
Keyword(s):
Phase Ii
◽
Phase II study of capecitabine single-agent therapy in patients with metastatic renal cell carcinoma
2006 ◽
Vol 24
(6)
◽
pp. 487-491
◽
Keyword(s):
Phase Ii
◽